Dow Jones

39 872,99

0,17%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Keryx Biopharmaceuticals, Inc. (delisted) (KERX)
Keryx Biopharmaceuticals, Inc. (delisted) (KERX) Actualités

KERX

Keryx Biopharmaceuticals, Inc. (delisted) (KERX)

Keryx Biopharmaceuticals, Inc. (delisted)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:KERX

1 2 3 4 5 6 7 8 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
26/12/2018	14h01	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
26/12/2018	12h02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
13/12/2018	22h42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
13/12/2018	21h54	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
13/12/2018	15h20	Edgar (US Regulatory)	Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
13/12/2018	15h09	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
13/12/2018	14h25	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
13/12/2018	13h49	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
13/12/2018	13h21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
12/12/2018	22h42	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
11/12/2018	18h00	GlobeNewswire Inc.	Keryx Biopharmaceuticals Stockholders Approve Merger with Akebia Therapeutics	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
03/12/2018	22h09	Edgar (US Regulatory)	Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
30/11/2018	14h55	GlobeNewswire Inc.	Glass Lewis Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics...	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
29/11/2018	13h00	GlobeNewswire Inc.	ISS Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
15/11/2018	23h15	Business Wire	Akebia Therapeutics and Keryx Biopharmaceuticals Announce Chairperson for Combined Company	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
13/11/2018	12h07	Edgar (US Regulatory)	Amended Quarterly Report (10-q/a)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
08/11/2018	22h30	GlobeNewswire Inc.	Keryx Biopharmaceuticals Announces Third Quarter 2018 Financial Results	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
06/11/2018	22h30	GlobeNewswire Inc.	Keryx Biopharmaceuticals to Release Third Quarter 2018 Financial Results on Thursday, November 8, 2018	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
30/10/2018	22h31	GlobeNewswire Inc.	Keryx Biopharmaceuticals Announces Filing of Definitive Joint Proxy Statement in Connection with Pending Merger with Akebia T...	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
30/10/2018	22h28	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
01/10/2018	15h16	GlobeNewswire Inc.	Keryx Biopharmaceuticals Announces Participation in an Upcoming Investor Conference	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
24/09/2018	21h31	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
09/08/2018	22h21	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
08/08/2018	13h00	GlobeNewswire Inc.	Keryx Biopharmaceuticals Announces Second Quarter 2018 Financial Results	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
02/08/2018	22h05	GlobeNewswire Inc.	Keryx Biopharmaceuticals to Host Conference Call of Second Quarter 2018 Financial Results on Wednesday, August 8, 2018	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
30/06/2018	01h12	PR Newswire (US)	WeissLaw LLP Investigates Keryx Biopharmaceuticals Inc.	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
29/06/2018	22h29	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
28/06/2018	13h00	Business Wire	Akebia Therapeutics & Keryx Biopharmaceuticals to Merge, Creating a Fully Integrated Company Focused on the Development & Com...	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
20/06/2018	15h21	GlobeNewswire Inc.	Keryx Biopharmaceuticals Announces Participation in a Renal Disease Panel at the JMP Securities Life Sciences Conference on T...	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)
31/05/2018	22h14	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:KERX	Keryx Biopharmaceuticals, Inc. (delisted)